Gene: BST2
Official Full Name: bone marrow stromal cell antigen 2provided by HGNC
Gene Summary: Bone marrow stromal cells are involved in the growth and development of B-cells. The specific function of the protein encoded by the bone marrow stromal cell antigen 2 is undetermined; however, this protein may play a role in pre-B-cell growth and in rheumatoid arthritis. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO09844 | BST2 Knockout cell line (HeLa) | Human | BST2 | 1:3~1:6 | Negative | Online Inquiry |
KO09845 | BST2 Knockout cell line (HCT 116) | Human | BST2 | 1:2~1:4 | Negative | Online Inquiry |
KO09846 | BST2 Knockout cell line (HEK293) | Human | BST2 | 1:3~1:6 | Negative | Online Inquiry |
BST2 Gene Knockout Cell Lines are expertly crafted cellular models that have undergone genetic modification to silence the BST2 gene, which encodes the bone marrow stromal antigen 1. This crucial research tool enables scientists to study the functional role of BST2 (also known as Tetherin) in diverse biological contexts, particularly its involvement in antiviral responses and tumor biology.
The primary mechanism of action of BST2 involves its ability to inhibit the release of enveloped viruses from infected cells, thereby restricting viral propagation. By utilizing BST2 Gene Knockout Cell Lines, researchers can effectively elucidate the cellular pathways influenced by BST2, gaining insights into the mechanisms of viral evasion and host immune responses. Furthermore, understanding BST2's function could pave the way for innovative therapeutic interventions, particularly in the development of antiviral drugs and cancer therapies.
The scientific importance of these cell lines extends to several applications in both research and clinical settings, including virology, immunology, and cancer research. They serve as invaluable platforms for drug screening, allowing for high-throughput analyses of potential therapeutics that target BST2-related pathways and enhance viral clearance or inhibit tumor progression.
What sets BST2 Gene Knockout Cell Lines apart from other available models is their precise genetic modification, which enables researchers to achieve results that are not influenced by the confounding effects of the BST2 gene. This targeted approach provides greater specificity in experimental results and enhances the reliability of data obtained from biological assays. Additionally, these cell lines are easy to culture and manipulate, making them accessible to labs with varying resources.
For researchers, clinicians, and pharmaceutical developers, the introduction of BST2 Gene Knockout Cell Lines represents a transformative resource in the quest for understanding complex biological systems and developing effective therapies. The detailed insights these models provide into BST2's roles can significantly advance current scientific knowledge and clinical applications.
Our company excels in the development of high-quality biological products, ensuring that researchers are equipped with tools that meet rigorous scientific standards and facilitate groundbreaking discoveries in life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.